CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors

2017-01-27 - English

This information was released for public disclosure on January 27, 2017 at 08.20 am CET.


CellaVision AB (public) today announced that its Nomination Committee proposes 
re-election of Sören Mellstig as Chairman of the Board and re-election of Christer Fåhraeus, Åsa Hedin, Roger Johanson, Torbjörn Kronander, Anna Malm Bernsten and Niklas Prager as Directors of the Board.


The Nomination Committee consists of the four largest shareholders represented by Nominatoion Committee Chairman Christer Fåhraeus (appointed by Christer Fåhraeus and companies), Bo Lundgren (appointed by Swedbank Robur Funds), Caroline Sjösten (appointed by Skandia Liv), Joel Eklund (appointed by Eklund & Peterson AB) and the Chairman of the Board Sören Mellstig.

The Nomination Committee's proposal for Board members:
Sören Mellstig - Chairman of the Board
Christer Fåhraeus - Board Member
Åsa Hedin - Board Member
Roger Johanson - Board Member
Torbjörn Kronander - Board Member
Anna Malm Bernsten - Board Member
Niklas Prager - Board Member

The Nomination Committee believes that the Board's expertise and experience thus meets the requirements that may arise. The Nomination Committee's other proposals to the Annual General Meeting, that will be held in Lund on CellaVision AB at 15:00 on May 5, will be published in the notice of the Annual General Meeting released to the public on
March 28, 2017.

 

 For more information, please contact:

Christer Fåhraeus, Chairman of the Nomination Committee, CellaVision AB
Tel: +46 (0) 705-60 90 00 | E-mail: cf@flatfrog.com

Sören Mellstig, Chairman of the Board, CellaVision AB
Tel: +46 (0) 70- 513 65 81| E-mail: soren@mellstig.se


About CellaVision

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China and Japan. In 2015 sales were SEK 239 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com

PDF version: Pdf

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analyst

ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93

Pareto Securities AB
Christian Lee
+46 8 402 52 67

 

Access our Student Resources

To access this resource, please provide the following information about yourself.